Familial Adenomatous Polyposis Clinical Trials

Find Familial Adenomatous Polyposis Clinical Trials Near You

A Personalized Surveillance and Intervention Protocol for Duodenal and Gastric Polyposis in Patients With Familial Adenomatous Polyposis

Status: Recruiting
Location: See all (2) locations...
Intervention Type: Procedure
Study Type: Observational
SUMMARY

The purpose of this study is to determine the efficacy and safety of a personalized surveillance and intervention protocol for duodenal and gastric polyposis in patients with familial adenomatous polyposis (FAP)

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Diagnosis of FAP, at least one of following: genetic diagnosis (proven APC germline mutation) and/or clinical diagnosis (\>100 colorectal adenomas in combination with a positive family history of FAP)

• Age 18 years or older

Locations
United States
Texas
MD Anderson
RECRUITING
Houston
Other Locations
Netherlands
Academic Medical Centre
RECRUITING
Amsterdam
Time Frame
Start Date: 2020-11-24
Estimated Completion Date: 2027-11
Participants
Target number of participants: 1000
Treatments
Personalized surveillance and intervention protocol
Related Therapeutic Areas
Sponsors
Collaborators: Hospital Clinic of Barcelona, The Netherlands Cancer Institute, Maria Sklodowska-Curie National Research Institute of Oncology, Hospital General Universitario de Alicante, IRCCS Azienda Ospedaliero-Universitaria di Bologna, University Hospital, Bonn, Radboud University Medical Center, St Mark's Hospital Foundation, M.D. Anderson Cancer Center, Leiden University Medical Center, Hvidovre University Hospital
Leads: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

This content was sourced from clinicaltrials.gov